Johanna Friedl-Naderer, Dyne Therapeutics’ chief commercial officer, sold 1,085 shares in two transactions priced from $18.88 to $24.35 per share. The sales leave her with 152,897 shares, giving investors the reported post-transaction ownership position and confirming both transactions used the S sale code.

Key Highlights

  • The transactions occurred between Sep. 4 and Sep. 8, 2026.
  • Both transactions carried SEC transaction code S, denoting sales.
  • Johanna Friedl-Naderer owned 152,897 shares after the transactions.

Dyne Therapeutics, Inc. (NASDAQ: DYN) Chief Commercial Officer Johanna Friedl-Naderer sold 1,085 shares across two transactions priced between $18.88 and $24.35 per share. The transactions took place between Sep. 4 and Sep. 8, 2026. Friedl-Naderer held 152,897 Dyne shares after the sales.

8 Both entries used transaction code S, the SEC classification for a sale. Per-share prices ranged from $18.88 to $24.35. The transaction record identifies Friedl-Naderer as Dyne Therapeutics’ chief commercial officer.